Leukemia Clinical Trials in Texas

Showing 581-597 of 597 trials

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

NCT00372775

This study will evaluate the safety, tolerability and efficacy of SU011248 in patients with non-small cell lung cancer with brain metastases.

Non-Small Cell Lung Cancer

Pfizer66 participantsStarted Mar 2007

Norwalk, Connecticut, United States • Cocoa Beach, Florida, United States • Merritt Island, Florida, United States +24 more locations

COMPLETEDPHASE242 miles

Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.

NCT00319969

The purpose of the study is to evaluate the objective tumor response rate of amrubicin or standard topotecan therapy when administered as second-line therapy to ED-SCLC patients who have chemotherapy sensitive recurrent or progressive.

Small Cell Lung Cancer

Celgene Corporation76 participantsStarted Apr 2006

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Berkeley, California, United States +44 more locations

PreviousPage 30 of 30

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.

Leukemia Trials in Other Cities

Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

CP-481,715 Nickel Allergy Study.

Trial of STAHIST in Seasonal Allergic Rhinitis

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Study of XL281 in Adults With Solid Tumors

STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Amonafide in Combination With Cytarabine in Secondary AML

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer

Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study

Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer

Other Conditions in Texas